Anti-LIV-1 / SLC39A6 Reference Antibody

• Catalog Number: orb1805475
• Category: Antibodies
• Description: Anti-LIV-1 / SLC39A6 Reference Antibodyand Monomethyl auristatin E (MMAE) used for the study of breast cancer.
• Clonality: Monoclonal
• Tested applications: ELISA, FA, FACS, Kinetics
• Reactivity: Human
• Isotype: IgG
• Purity: > 95%
• Conjugation: Unconjugated
• MW: 145.5 kDa
• Target: LIV-1 / SLC39A6
• Endotoxins: < 1 EU/mg
• Storage: -80°C
• Buffer/Preservatives: 100 mM Pro-Ac 20 mM Arg pH 5.0
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin)is more than 98.2% ;determined by SEC-HPLC.

Immobilized human LIV 1; His Tag at 2 μg/mL can bind Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin);EC50=0.007652μg/mL.

Human LIV1 CHOS cells were stained with Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin) and negative control protein respectively; washed and then followed by PE and analyzed with FACS; EC220=0.07456 ug/mL.